Clinical Trials with Mesenchymal Stem Cell Therapies for Osteoarthritis: Challenges in the Regeneration of Articular Cartilage
International Journal of Molecular Sciences · 09.06.2023 · 24 (12) · 9939
DOI: 10.3390/ijms24129939 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.06.2023. Verfasst von Diego de Carvalho Carneiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador 40296-710, Bahia, Brazil. Hauptthemen laut MEDLINE: Cartilage, Articular, Osteoarthritis, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oswaldo Cruz Foundation.
Abstract (Originalsprache)
Osteoarthritis (OA) is a whole-joint disease primarily characterized by the deterioration of hyaline cartilage. Current treatments include microfracture and chondrocyte implantation as early surgical strategies that can be combined with scaffolds to repair osteochondral lesions; however, intra-articular (IA) injections or implantations of mesenchymal stem cells (MSCs) are new approaches that have presented encouraging therapeutic results in animal models and humans. We critically reviewed clinical trials with MSC therapies for OA, focusing on their effectiveness, quality, and outcomes in the regeneration of articular cartilage. Several sources of autologous or allogeneic MSCs were used in the clinical trials. Minor adverse events were generally reported, indicating that IA applications of MSCs are potentially safe. The evaluation of articular cartilage regeneration in human clinical trials is challenging, particularly in the inflammatory environment of osteoarthritic joints. Our findings indicate that IA injections of MSCs are efficacious in the treatment of OA and the regeneration of cartilage, but that they may be insufficient for the full repair of articular cartilage defects. The possible interference of clinical and quality variables in the outcomes suggests that robust clinical trials are still necessary for generating reliable evidence with which to support these treatments. We suggest that the administration of just-sufficient doses of viable cells in appropriate regimens is critical to achieve effective and durable effects. In terms of future perspectives, genetic modification, complex products with extracellular vesicles derived from MSCs, cell encapsulation in hydrogels, and 3D bioprinted tissue engineering are promising approaches with which to improve MSC therapies for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador 40296-710, Bahia, Brazil.
- SENAI Institute of Advanced Health Systems, University Center SENAI CIMATEC, Salvador 41650-010, Bahia, Brazil.
ORCID-Profile: Diego de Carvalho Carneiro, Lila Teixeira de Araújo, Patrícia Kauanna Fonseca Damasceno, Josiane Dantas Viana Barbosa, Milena Botelho Pereira Soares
Förderung
- Oswaldo Cruz Foundation
Zitieren
APA
Carneiro, D. C., Araújo, L. T., Santos, G. C., Damasceno, P. K. F., Vieira, J. L., Santos, R. R. D., Barbosa, J. D. V., & Soares, M. B. P. (2023). Clinical Trials with Mesenchymal Stem Cell Therapies for Osteoarthritis: Challenges in the Regeneration of Articular Cartilage. International Journal of Molecular Sciences, 24(12), 9939. https://doi.org/10.3390/ijms24129939
Vancouver
Carneiro DC, Araújo LT, Santos GC, Damasceno PKF, Vieira JL, Santos RRD, et al. Clinical Trials with Mesenchymal Stem Cell Therapies for Osteoarthritis: Challenges in the Regeneration of Articular Cartilage. International Journal of Molecular Sciences. 2023;24(12):9939. doi:10.3390/ijms24129939
BibTeX
@article{Carneiro2023,
author = {Carneiro, Diego de Carvalho and Araújo, Lila Teixeira de and Santos, Girlaine Café and Damasceno, Patrícia Kauanna Fonseca and Vieira, Jaqueline Leite and Santos, Ricardo Ribeiro Dos and Barbosa, Josiane Dantas Viana and Soares, Milena Botelho Pereira},
title = {Clinical Trials with Mesenchymal Stem Cell Therapies for Osteoarthritis: Challenges in the Regeneration of Articular Cartilage},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {12},
pages = {9939},
doi = {10.3390/ijms24129939}
}
EUVIMED